Home
Explore services
Integrated solutions
Data & analytics
Tailored Reporting
Strategy & consulting
AI
Industry focus
Enterprise, mid-market & emerging pharmaceutical
Biotechnology
Financial Institutions
Education
Professional services
How we help
Pricing strategy & market access
Health technology assessment
Regulatory compliance
Commercial strategy & launch planning
Contact us
Responsive Menu
Home
Explore services
▼
Integrated solutions
Data & analytics
Tailored Reporting
Strategy & consulting
AI
Industry focus
▼
Enterprise, mid-market & emerging pharmaceutical
Biotechnology
Financial Institutions
Education
Professional services
How we help
▼
Pricing strategy & market access
Health technology assessment
Regulatory compliance
Commercial strategy & launch planning
Contact us
LOGIN
Blogs
Navigating the pricing landscape: A year of innovation, insight, and impact
By Wayne Speechly, CEO
2 December 2024
Read More
Insights into value-based pricing approaches for oncology products in Germany
29 November 2024
Read More
When is the Exciting Promise of AI in Pharmaceutical Pricing and Market Access Coming?
28 November 2024
Read More
GPI launches oncology-specific value-based pricing methodology
1 November 2024
Read More
The proposed EU HTA, a concern for orphan drugs in the future?
27 February 2023
Read More
Is Gene Therapy still on the brink of Commercial Success?
8 February 2023
Read More
State Price Transparency Reporting: 4 strategies to reduce the risk of non-compliance
23 November 2022
Read More
Starting with the end in mind – creating sustainable access to medicines
9 November 2022
Read More
Stairway to Seven: GPI celebrating 7 years in business
29 September 2022
Read More
What should drug pricing reforms look like in the United States?
By Margaret Labban, PhD
1 June 2022
Read More
1
2
3
Next »
Yearly Archives
2025
2024
2023
2022
2021
Stay Informed
Sign up to receive the latest news and trends
straight into your inbox from GPI
LOGIN 
